Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Systemic sclerosis (SSc) is a rare autoimmune disease, which is potentially lethal. The physiopathology of the disease is still incompletely elucidated although the role of fibroblasts, endothelial cells (ECs), immune cells. and the environment (i.e., oxidative stress) has been demonstrated. This is...
Main Authors: | Pauline Rozier, Alexandre Maria, Radjiv Goulabchand, Christian Jorgensen, Philippe Guilpain, Danièle Noël |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02938/full |
Similar Items
-
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
by: Alexandre T. J. Maria, et al.
Published: (2018-12-01) -
Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function
by: Guillaume Fonteneau, et al.
Published: (2017-09-01) -
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
by: Alexandre T. J. Maria, et al.
Published: (2018-11-01) -
Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
by: Alexandre Thibault Jacques Maria, et al.
Published: (2019-01-01) -
Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
by: Pauline Rozier, et al.
Published: (2021-06-01)